{
  "id": 1478,
  "text": "Meta-analysis of eight studies726,1265,1433,1437,1458-1461 showed that for LACC, CCRT and with cisplatin-based doublet chemotherapy significantly improved the OS ( $\\mathrm { { O R } } = 0 .6 5$ $\\left[ 9 5 \\% \\mathrm { C I } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Meta-analysis of eight studies726,1265,1433,1437,1458-1461 showed that for LACC, CCRT and with cisplatin-based doublet chemotherapy significantly improved the OS ( $\\mathrm { { O R } } = 0 .6 5$ $\\left[ 9 5 \\% \\mathrm { C I } = 0 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "同步放化疗联合以顺铂为基础的双药化疗对于局部晚期宫颈癌患者的总生存率（OS）具有显著的提升效果。根据多项研究的荟萃分析结果表明，使用此治疗方案可以显著改善总生存率，其有效性已经在临床上得到了验证。因此，对于诊断为局部晚期宫颈癌的患者，应用这种治疗策略可能会带来更好的预后。",
  "query": "根据提供的内容，我生成以下问题：\n\n**同步放化疗联合以顺铂为基础的双药化疗对于局部晚期宫颈癌患者的总生存率（OS）有何提升作用？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的内容，我生成以下问题：\n\n**同步放化疗联合以顺铂为基础的双药化疗对于局部晚期宫颈癌患者的总生存率（OS）有何提升作用？**\n\n<reference text>: Meta-analysis of eight studies726,1265,1433,1437,1458-1461 showed that for LACC, CCRT and with cisplatin-based doublet chemotherapy significantly improved the OS ( $\\mathrm { { O R } } = 0 .6 5$ $\\left[ 9 5 \\% \\mathrm { C I } = 0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "同步放化疗联合以顺铂为基础的双药化疗对于局部晚期宫颈癌患者的总生存率（OS）具有显著的提升效果。根据多项研究的荟萃分析结果表明，使用此治疗方案可以显著改善总生存率，其有效性已经在临床上得到了验证。因此，对于诊断为局部晚期宫颈癌的患者，应用这种治疗策略可能会带来更好的预后。"
}